RCS - One Health Group PLC - Appointment of Commercial Manager

One HealthAnnouncement

06/05/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260506:nRSF1327Da&default-theme=true

RNS Number : 1327D  One Health Group PLC  06 May 2026

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Appointment of Commercial Manager

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded
surgical procedures for patients referred from the NHS through 'Patient
Choice', announces the appointment of Joe Hopwood as Commercial Manager.

 

Joe joins One Health from NHS South Yorkshire Integrated Care Board where he
worked as the transformation and delivery manager. Prior to joining the NHS,
Joe was the programme and performance manager at South Yorkshire Police. In
his new role at One Health, Joe will be involved in several key areas across
the business, including contract negotiations and commercial oversight, and
will support the Company in its growth journey and continued execution of its
strategy.

 

Joe is skilled in strategic contractual and commercial strategies and
stakeholder management with proven national expertise in elective care
commissioning legislation, contracts and guidance within the NHS.

Adam Binns, CEO of One Health Group, commented: "This year has been a pivotal
period for One Health, and the Board felt now was the right time to further
strengthen the management team with this appointment. Joe's NHS experience,
strong commercial awareness, and his analytical capabilities will prove
invaluable as we continue to grow and develop. We are delighted to welcome
him, and I am confident he will add immense value and insight."

Commenting on his new role, Joe Hopwood said: "I'm thrilled to be joining One
Health Group during a period of significant momentum. The team's commitment to
improving NHS patient access to high-quality care really stands out, and I'm
looking forward to building on this by developing strong partnerships and
supporting the Company's continued growth."

 

If you wish to keep up to date on Company news please email:
onehealth@walbrookpr.com (mailto:onehealth@walbrookpr.com)

 

For more information, please contact:

 

 One Health Group plc                                                                                                www.onehealth.co.uk/investors (http://www.onehealth.co.uk/investors)

 Derek Bickerstaff, Chairman                                                                                         Via Walbrook PR

 Adam Binns, CEO

 Panmure Liberum (Nominated Adviser and Broker)                                                                      Tel: +44 (0)20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

                                             (mailto:onehealth@walbrookpr.com)
 Alice Woodings / Paul McManus /

                                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
 Rachel Broad

                                               +44 (0)7747 515 393

 

About One Health Group plc (www.onehealth.co.uk (http://www.onehealth.co.uk) )

One Health engages 88 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the year to
March 2026 provided much needed care to 18,931 new patients, through over
50,000 consultations and over 8,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 140 professionals across 14
independent hospitals and 40 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from 29 ICBs across England as well as contracts with local NHS trusts
to transfer their internal waiting list patients to One Health for quicker
treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman
and Adam Binns, Chief Executive Officer, which offers insights into the
Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement
(https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSLFUIEMSELI



            Copyright 2019 Regulatory News Service, all rights reserved